57. Nakamura K, Sho M, Akahori T, Nagai M, Nishiwada S, Nakagawa K, Tanaka T, Kichikawa K, Tamamoto T, Hasegawa M, Mitoro A, Yoshiji H, Ikeda N. A Comparison Between Plastic and Metallic Biliary Stent Placement in Patients Receiving Preoperative Neoadjuvant Chemoradiotherapy for Resectable Pancreatic Cancer. World J Surg. 43(2):642-648, 2019

58. Owari T, Tanaka N, Nakai Y, Asakawa I, Tomizawa M, Miyake M, Morizawa Y, Hori S, Anai S, Hasegawa M, Fujimoto K. Localized prostate cancer with pelvic arteriovenous malformation treated with low-dose-rate brachytherapy after transcatheter embolization: Two case reports. IJU Case Rep. 2(2):90-94, 2019

59. Nakai Y, Tanaka N, Asakawa I, Anai S, Miyake M, Hori S, Morizawa Y, Tatsumi Y, Hasegawa M, Fujii T, Fujimoto K. Quality of life in patients who underwent 125I brachytherapy, 125I brachytherapy combined with three-dimensional conformal radiation therapy, or intensity-modulated radiation therapy, for prostate cancer. J Radiat Res. 60(2):270-280, 2019

60. Kawaguchi T, Sawabata N, Miura S, Kawai N, Yasukawa M, Tojo T, Taniguchi S. Prognostic impact of underlying lung disease in pulmonary wedge resection for lung cancer. Int J Clin Oncol. 24(4):366-374, 2019

61. Miyake M, Tanaka N, Asakawa I, Owari T, Hori S, Morizawa Y, Nakai Y, Inoue T, Anai S, Torimoto K, Hasegawa M, Fujii T, Konishi N, Fujimoto K. The impact of the definition of biochemical recurrence following salvage radiotherapy on outcomes and prognostication in patients with recurrent prostate cancer after radical prostatectomy: a comparative study of three definitions. Prostate Int. 7(2):47-53, 2019

62. Morimoto Y, Inoue K, Matsuda R, Miyasaka T, Wakai N, Yamaki K, Miura S, Asakawa I, Tamamoto T, Hasegawa M. Feasibility and efficacy of individualized radiation therapy for primary central nervous system lymphoma: Radiation treatment planning according to treatment response by radiographic assessment. J Nara Med Assoc. 70(1,2,3):1-19, 2019

63. Mori T, Nakane H, Iwamoto T, Krokidis MG, Chatgilialoglu C, Tanaka K, Kaidoh T, Hasegawa M, Sugiura S. High levels of oxidatively generated DNA damage 8,5′-cyclo-2′-deoxyadenosine accumulate in the brain tissues of xeroderma pigmentosum group A gene-knockout mice. DNA Repair (Amst). 80:52-58, 2019

64. Hirata T, Kinoshita M, Tamari K, Seo Y, Suzuki O, Wakai N, Achiha T, Umehara T, Arita H, Kagawa N, Kanemura Y, Shimosegawa E, Hashimoto N, Hatazawa J, Kishima H, Teshima T, Ogawa K. 11C-methionine-18F-FDG dual-PET-tracer-based target delineation of malignant glioma: evaluation of its geometrical and clinical features for planning radiation therapy. J Neurosurg. 131(3):676-686, 2019

65. Nakai Y, Tanaka N, Asakawa I, Torimoto K, Miyake M, Anai S, Fujii T, Hasegawa M, Fujimoto K. Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer. J Contemp Brachytherapy. 11(5):409-416, 2019

66. Kawaguchi H, Soejima T, Ishibashi N, Akiba T, Hasegawa M, Isobe K, Ito H, Imai M, Ejima Y, Hata M, Sasai K, Shimoda E, Oguchi M, Akimoto T. National survey on total-body irradiation prior to reduced-intensity stem cell transplantation in Japan: The Japanese Radiation Oncology Study Group. J Radiat Res. 60(5):579-585, 2019

67. Sugimoto T, Matsuda R, Tamamoto T, Hontsu S, Yamaki K, Miura S, Park YS, Nakase H, Hasegawa M. Linac-Based Fractionated Stereotactic Radiotherapy with a Micro-Multileaf Collimator for Brainstem Metastasis. World Neurosurg. 132:e680-e686, 2019